Financial Performance - The company's basic earnings per share decreased by 61.13% to 0.2130 yuan in 2024 from 0.5480 yuan in 2023 [1] - Net profit fell by 60.67% to 0.35 billion yuan in 2024 compared to 0.89 billion yuan in 2023 [1] - Operating revenue declined by 19.52% to 4.37 billion yuan in 2024 from 5.43 billion yuan in 2023 [1] - Return on equity dropped by 61.64% to 2.29% in 2024 from 5.97% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 47.4232 million shares, accounting for 34.44% of the circulating shares, a decrease of 6.5804 million shares from the previous period [1] - UBS AG reduced its holdings by 50% to 777.19 thousand shares, representing 5.64% of total share capital [2] - New entrants among the top shareholders include He Jianbiao, Feng Jiaqing, and Niu Zhengxiang, with holdings of 121.91 thousand, 112.49 thousand, and 108.00 thousand shares respectively [2] Dividend Distribution - No specific information on dividend distribution or plans was provided in the documents [3]
透景生命:2024年报净利润0.35亿 同比下降60.67%